News | January 02, 2024
Inspira Technologies closes on $3.88 million RDO
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
Azelis will be the exclusive distributor for inulin, oligofructose, scFOS, texturized wheat proteins, faba beans, Beta-glucans, meatless solution
The countrywide initiative aims to spread awareness, educate the public & ensure that no one is left behind in the fight against respiratory diseases
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
Subscribe To Our Newsletter & Stay Updated
